<DOC>
	<DOCNO>NCT01868191</DOCNO>
	<brief_summary>The aim present study ass , well 6 12 month follow therapy benfotiamine influence therapy intraepidermal nerve fiber density ( skin biopsy ) neuropathic symptoms deficit people type 1 2 diabetes mellitus diabetic sensomotoric neuropathy .</brief_summary>
	<brief_title>Effects Benfotiamine Intraepidermal Nerve Fiber Density ( IENFD )</brief_title>
	<detailed_description />
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Benphothiamine</mesh_term>
	<mesh_term>Thiamine</mesh_term>
	<criteria>Have type 1 type 2 diabetes mellitus base disease diagnostic criterion ( WHO ) classification ongoing insulin or/and oral antidiabetic therapy stable regimen previous 3 month Male female subject age 18 75 year , inclusive Have HbA1c level ≤ 9.5 % without optimize potential mTCNS ( modify Toronto Clinical Neuropathy Score ) ≥ ( equal ) 6 ) OR ( score MNSI ( Michigan Neuropathy Screening Instrument ) questionnaire ≥4 score MNSI examination ≥2.5 ) Medical history without major pathology ( exception type 2 diabetes ) judge investigator , especially major peripheral artery disease . Body mass index ( BMI ) 25 45kg/m2 , inclusive Subjects secondary form diabetes due pancreatitis . Current previous treatment ( le 6 month ) benfotiamine , Bvitamins , vitamin B complex , alpha lipoic acid actovegin . Have contraindication , know allergy , hypersensitivity benfotiamine . Have contraindication , know allergy , hypersensitivity local anesthetic . Neuropathy origin diabetes . Other severe pain might impair assessment neuropathic pain . Treatment one following : tricyclic antidepressant , serotonin norepinephrine reuptake inhibitor , anticonvulsant , class I antiarrhythmics Nachannel inhibition ( mexiletine , flecainid , propafenon others ) neuroleptic patient receive drug neuropathic pain .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Neuropathy</keyword>
</DOC>